|
| 35167414 | A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine. | Ocul Immunol Inflamm | 2023 |
| 37253802 | Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan. | Sci Rep | 2023 |
| 37145198 | COVID Vaccine-Associated Uveitis. | Ocul Immunol Inflamm | 2023 |
| 37039948 | Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial. | Jpn J Ophthalmol | 2023 |
| 36744150 | Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study. | Front Med (Lausanne) | 2023 |
| 36280611 | COVID-19 vaccination-related intraocular inflammation in Japanese patients. | Graefes Arch Clin Exp Ophthalmol | 2023 |
| 32945715 | Clinical Characteristics, Management, and Factors Associated with Poor Visual Prognosis of Acute Retinal Necrosis. | Ocul Immunol Inflamm | 2022 |
| 35616725 | Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo. | Graefes Arch Clin Exp Ophthalmol | 2022 |
| 35478375 | Prognostic value of subfoveal choroidal thickness in new-onset acute Vogt-Koyanagi-Harada disease. | Clin Exp Ophthalmol | 2022 |
| 35611393 | Compromised blood flow of the optic nerve head in acute retinal necrosis. | Clin Exp Ophthalmol | 2022 |
| 35670922 | Use of systemic corticosteroids in patients newly registered at a claims database with a diagnosis of non-infectious uveitis: results from a real-world claims database analysis. | Jpn J Ophthalmol | 2022 |
| 35366082 | Correction to: Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study. | Graefes Arch Clin Exp Ophthalmol | 2022 |
| 35595951 | Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study. | Jpn J Ophthalmol | 2022 |
| 35940244 | Reply to Comment on: SUN Classification Criteria for Vogt-Koyanagi-Harada Disease. | Am J Ophthalmol | 2022 |
| 36142662 | Comparative Analysis of Serum microRNA in Diagnosed Ocular Sarcoidosis versus Idiopathic Uveitis with Ocular Manifestations of Sarcoidosis. | Int J Mol Sci | 2022 |
| 36359546 | Automated Quantitative Analysis of Anterior Segment Inflammation Using Swept-Source Anterior Segment Optical Coherence Tomography: A Pilot Study. | Diagnostics (Basel) | 2022 |
| 34982220 | Long-term changes of choroidal blood flow velocity in Vogt-Koyanagi-Harada disease. | Graefes Arch Clin Exp Ophthalmol | 2022 |
| 35034215 | Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study. | Graefes Arch Clin Exp Ophthalmol | 2022 |
| 32459545 | Effect of In Vivo Expansion of Regulatory T Cells with IL-2/anti-IL-2 Antibody Complex Plus Rapamycin on Experimental Autoimmune Uveoretinitis. | Ocul Immunol Inflamm | 2021 |
| 33694024 | Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. | Jpn J Ophthalmol | 2021 |
| 33528647 | Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure. | Graefes Arch Clin Exp Ophthalmol | 2021 |
| 33723637 | Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study. | Graefes Arch Clin Exp Ophthalmol | 2021 |
| 34181111 | Prevalence and incidence rates and treatment patterns of non-infectious uveitis in Japan: real-world data using a claims database. | Jpn J Ophthalmol | 2021 |
| 34283294 | Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study. | Graefes Arch Clin Exp Ophthalmol | 2021 |
| 33346626 | MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. | Retina | 2021 |
| 33057904 | Pachychoroid: current concepts on clinical features and pathogenesis. | Graefes Arch Clin Exp Ophthalmol | 2021 |
| 32972915 | Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behçet's disease. | Br J Ophthalmol | 2021 |
| 32586933 | Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. | Br J Ophthalmol | 2021 |
| 30806525 | Clinical Features, Treatment, and Visual Outcomes of Japanese Patients with Posterior Scleritis. | Ocul Immunol Inflamm | 2020 |
| 31876889 | SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY. | Retina | 2020 |
| 31999379 | Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease. | J Gastroenterol Hepatol | 2020 |
| 32447586 | Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter study. | Jpn J Ophthalmol | 2020 |
| 32417356 | Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration: A Prospective Study. | Ophthalmol Retina | 2020 |
| 32328757 | Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. | Graefes Arch Clin Exp Ophthalmol | 2020 |
| 32437414 | Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population. | PLoS One | 2020 |
| 32377746 | Anti⿿inflammatory effects of the NF⿿κB inhibitor dehydroxymethylepoxyquinomicin on ARPE⿿19 cells. | Mol Med Rep | 2020 |
| 32250731 | The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings. | Ocul Immunol Inflamm | 2020 |
| 30950670 | Anti-Inflammatory Effect of Dehydroxymethylepoxyquinomicin, a Nuclear factor-κB Inhibitor, on Endotoxin-Induced Uveitis in Rats In vivo and In vitro. | Ocul Immunol Inflamm | 2020 |
| 29563110 | Clinical features of patients with diabetic anterior uveitis. | Br J Ophthalmol | 2019 |
| 31318394 | A Patient With Type 1 Diabetes, Visual Acuity Loss, and Retinal Thickening. | JAMA Ophthalmol | 2019 |
| 30821631 | Epidemiology of Macular Edema in Uveitis. | Ocul Immunol Inflamm | 2019 |
| 30552891 | The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab. | Am J Ophthalmol | 2019 |
| 30395750 | Association Study of <i>ARMC9</i> Gene Variants with Vogt-Koyanagi-Harada Disease in Japanese Patients. | Ocul Immunol Inflamm | 2019 |
| 29666121 | Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. | Br J Ophthalmol | 2019 |
| 28033228 | SUB-TENON TRIAMCINOLONE ACETONIDE INJECTION IN A PREGNANT PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE. | Retin Cases Brief Rep | 2018 |
| 29974277 | Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy. | Jpn J Ophthalmol | 2018 |
| 30405804 | Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer. | Oncol Lett | 2018 |
| 28440583 | Topical antibiotics and intravitreal injections. | Acta Ophthalmol | 2018 |
| 29122577 | Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience. | Am J Ophthalmol | 2018 |
| 27046676 | Investigation of the association between IL10 gene polymorphisms and Vogt-Koyanagi-Harada disease in a Japanese population. | Ophthalmic Genet | 2017 |